Revatropate

CAS: 149926-91-0

Ref. 3D-FR159755

Produktinformation

• Name: Revatropate
• Synonyme: (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate, (R)-3-Quinuclidinyl (S)-beta-hydroxy-alpha-(2-(R)-methylsulfinyl)ethyl)hydratropate, Uk-112,166, Unii-3W7L15V40W, Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-, (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate

Beschreibung

Revatropate is a chiral compound that belongs to the class of antimuscarinic drugs. It is used to treat motility disorders such as constipation, diarrhea, and irritable bowel syndrome. Revatropate has been shown to have high activity against syncytial virus infections and inflammatory bowel disease. This drug also inhibits the synthesis of phospholipase A 2 , which has been implicated in the pathogenesis of autoimmune diseases. The molecular mechanism for this effect is not known, but it may be due to the inhibition of water vapor loss from the bladder by reducing ileal motility.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 365.49 g/mol
• Formel: C₁₉H₂₇NO₄S
• Reinheit: Min. 95%